Department of Pediatrics, Emory University, Atlanta, GA, United States.
Center for CF and Airways Disease Research, Children's Healthcare of Atlanta, Atlanta, GA, United States.
Front Immunol. 2023 Sep 21;14:1194253. doi: 10.3389/fimmu.2023.1194253. eCollection 2023.
In chronic cystic fibrosis (CF) lung disease, neutrophilic inflammation and T-cell inhibition occur concomitantly, partly due to neutrophil-mediated release of the T-cell inhibitory enzyme Arg1. However, the onset of this tonic inhibition of T cells, and the impact of pulmonary exacerbations (PEs) on this process, remain unknown.
Children with CF aged 0-5 years were enrolled in a longitudinal, single-center cohort study. Blood (n = 35) and bronchoalveolar lavage (BAL) fluid (n = 18) were collected at stable outpatient clinic visits or inpatient PE hospitalizations and analyzed by flow cytometry (for immune cell presence and phenotype) and 20-plex chemiluminescence assay (for immune mediators). Patients were categorized by PE history into (i) no prior PE, (ii) past history of PE prior to stable visit, or (iii) current PE.
PEs were associated with increased concentration of both pro- and anti-inflammatory mediators in BAL, and increased neutrophil frequency and G-CSF in circulation. PE BAL samples showed a trend toward an increased frequency of hyperexocytic "GRIM" neutrophils, which we previously identified in chronic CF. Interestingly, expression levels of the T-cell receptor associated molecule CD3 and of the inhibitory programmed death-1 (PD-1) receptor were respectively decreased and increased on T cells from BAL compared to blood in all patients. When categorized by PE status, CD3 and PD-1 expression on blood T cells did not differ among patients, while CD3 expression was decreased, and PD-1 expression was increased on BAL T cells from patients with current PE.
Our findings suggest that airway T cells are engaged during early-life PEs, prior to the onset of chronic neutrophilic inflammation in CF. In addition, increased blood neutrophil frequency and a trend toward increased BAL frequency of hyperexocytic neutrophils suggest that childhood PEs may progressively shift the balance of CF airway immunity towards neutrophil dominance.
在慢性囊性纤维化(CF)肺部疾病中,中性粒细胞炎症和 T 细胞抑制同时发生,部分原因是中性粒细胞介导的 T 细胞抑制酶 Arg1 的释放。然而,这种 T 细胞的紧张抑制的发作,以及肺部恶化(PEs)对这一过程的影响,仍然未知。
患有 CF 的 0-5 岁儿童参加了一项纵向、单中心队列研究。在稳定的门诊就诊或住院 PEs 期间采集血液(n=35)和支气管肺泡灌洗液(BAL)(n=18),并通过流式细胞术(用于免疫细胞存在和表型)和 20 plex 化学发光测定(用于免疫调节剂)进行分析。根据 PEs 史将患者分为(i)无既往 PEs,(ii)在稳定就诊前有既往 PEs 史,或(iii)当前 PEs。
PEs 与 BAL 中促炎和抗炎介质的浓度增加有关,并与循环中性粒细胞频率和 G-CSF 增加有关。PE BAL 样本显示出“GRIM”高细胞性中性粒细胞频率增加的趋势,我们之前在慢性 CF 中发现了这种现象。有趣的是,与血液相比,所有患者的 BAL 中的 T 细胞上的 T 细胞受体相关分子 CD3 和抑制性程序性死亡-1(PD-1)受体的表达水平分别降低和增加。按 PEs 状态分类时,血液 T 细胞上的 CD3 和 PD-1 表达在患者之间没有差异,而当前 PEs 患者的 BAL T 细胞上 CD3 表达降低,PD-1 表达增加。
我们的研究结果表明,气道 T 细胞在 CF 中的慢性中性粒细胞炎症发作之前,在生命早期的 PEs 期间被激活。此外,血液中性粒细胞频率增加和 BAL 中高细胞性中性粒细胞频率增加的趋势表明,儿童期 PEs 可能使 CF 气道免疫的平衡逐渐向中性粒细胞优势转变。